This Week's Poll

At the recent BioPartner Forum it was stated the internal market is insufficient for a UK Life Science company to develop a technology, product or service at a rate that will return investor value. Do you

Supported by Medilink UK

NHS adoption of innovation - Kevin Wilson of - Innova Partnerships Ltd - 9:14:00am Jun-30th

I’ve been to three innovation events this month and am concerned there is still a lot of talk and not enough adoption taking place of new technologies. At each event companies expressed the same challenge: the NHS, as the largest purchaser of products and services, is not being adequately incentivised to explore new technologies and instead the procurement officers are just beating down the costs of the current suppliers. How can this be addressed with the cuts and efficiencies being driven down from the top which still seem incapable of looking at the overall cost savings as opposed to individual budget savings?

Agree/Disagree + add comment
 
 
t